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ABSTRACT 
 
ATP is a neurotransmitter at several sites in the central and peripheral nervous systems, 
particularly in pathways concerned with nociceptive input processing. This realization has 
prompted a number of studies to investigate how manipulating the action of ATP might lead to 
new forms of pain treatment. There is, however, a dearth of information about the mechanisms 
regulating the release of ATP in response to depolarization and how its effect on target neurons 
can be pharmacologically modulated. The present work was, therefore, focussed on two main 
aspects concerning the action of ATP. First, a new method, based on the use of PC12 cells in 
culture, was set up to investigate the characteristics of quantal release of endogenous ATP. 
Second, the characteristics of activation, desensitization and pharmacological modulation of 
the main class of ionotropic P2X3 receptors on sensory ganglia were studied. All these results 
were obtained with whole-cell patch clamping and calcium imaging experiments. 
PC12 cells contain ATP in dense core vesicles in which it is co-stored with catecholamines. By 
applying depolarizing pulses to PC12 cells, transient inward currents (STICs) were detected 
only from PC12 cells that formed clusters with their closely juxta-apposed membranes, thus 
creating a restricted extracellular space for the local action of ATP. STICs were Ca2+ 
dependent events due to quantal release of endogenous ATP (acting on P2X2 receptors). The 
action of ATP was readily facilitated by extracellular Zn2+ and blocked by the selective ATP 
receptor antagonist PPADS. STICs originating from clusters of PC12 cells may therefore be a 
useful, cheap and simple model to study ATP-mediated quantal currents. 
P2X3 receptors underlying the algogenic effects of ATP were characterized on trigeminal 
ganglion (TG) neurons in culture, and compared with other nociception-related receptors like 
the TRPV1 ones. Under the present experimental conditions, TG neurons remained functional 
for many days. Their P2X3 and TRPV1 receptors were differentially upregulated by chronic 
application (24 h) of NGF and 5-HT, respectively. Such an effect of NGF was selective for 
P2X3 receptors, because it spared GABAA receptors that actually acquired accelerated receptor 
desensitization and deactivation. 
Because strong desensitization rapidly curtails the effects of P2X3 receptors, we considered this 
process as an important target to up or down regulate their activity. To identify the sites 
involved in desensitization, single point mutations in the extracellular loop of P2X3 receptors 
(heterologously expressed in HEK cells) were introduced to specifically affect the onset of 
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desensitization and/or the recovery from it, indicating that these two properties were 
structurally distinct. Could the prototypical migraine mediator CGRP induce pain by affecting 
P2X3 receptors, especially their desensitization properties? This question was examined by 
using cultured TG neurons as a validated model to study P2X3 receptors in the presence of 
CGRP. CGRP largely and powerfully potentiated the amplitude of responses mediated by P2X3 
receptors. This phenomenon was attained not only via increasing their membrane expression 
(due to accelerated trafficking), but also by decreasing their desensitization characteristics. The 
action of CGRP was dependent on activation of intracellular PKA and PKC, and did not 
involve modulation of TRPV1 receptors. These data provide a novel molecular substrate for 
the algogenic action of CGRP. 
 
 
 
 3 
INTRODUCTION 
 
1. ATP as a neurotransmitter 
Adenosine triphosphate (ATP) is one of the most widespread compounds in living cells. It is 
now well established that it plays an important role not only in energy supply but also in 
intercellular communication. 
Non-neuronal cells, like those of the vascular system after mechanical stimulation (red blood 
cells, endothelial cells, smooth muscle cells, platelets during aggregation), epithelial cells 
lining tubes and sacs (e.g. intestine and bladder), adrenal chromaffin cells, astrocytes and glial 
cells are important stores of ATP ready for release (Burnstock, 2000; Bodin and Burnstock, 
2001). ATP is indeed physiologically released by a wide variety of sources (mainly via 
vesicular release or ATP-binding cassette transporters; Lazarowski et al., 2003). The 
concentration of ATP in such vesicles can be particularly high: for example, dense core 
vesicles of chromaffin cells (and of their relatives, the PC12 cells) contain ATP at a 
concentration exceeding 100 mM (Njus et al., 1986). Remarkably, large amounts of ATP can 
be released from damaged tissues and during tissue inflammation, thus pointing to this 
substance as one of the major contributors to nociceptive input transmission (see section 3; 
Burnstock, 2001; Cook and McCleskey, 2002). 
In addition to non-neuronal cells, neurons represent a notable source of ATP, as this molecule 
can act as a neurotransmitter, which is widely used in both peripheral and central nervous 
systems (Dunn et al., 2001; North and Verkhratsky, 2006; Pankratov et al., 2006; see below).  
In neurons, ATP can be released from dedicated vesicle pools or it can be co-stored and/or co-
released together with classical neurotransmitters. For example, ATP is released in association 
with acetylcholine at neuromuscular junctions (Silinsky and Redman, 1996), with noradrenalin 
and neuropeptide Y from sympathetic neurons (Huidobro-Toro and Donoso, 2004), with 
GABA from spinal dorsal horn neurons (Jo and Schlichter, 1999), with catecholamines from 
peripheral and central noradrenergic neurons (von Kugelgen and Starke, 1985; Vizi and 
Burnstock, 1988; Poelchen et al., 2001), and with calcitonin gene-related peptide (CGRP) and 
substance P (SP) from sensory neurons (Sweeney et al., 1989; Bodin and Burnstock, 2001). 
On the basis of the frequent co-release of ATP with other neurotransmitters (and depending on 
the expression and localization of ATP receptors at the correspondent sites; see section 2) there 
is potential for a double role for ATP, namely as a neurotransmitter itself (or modulator of the 
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effects of other neurotransmitters) at postsynaptic level, or as a modulator of neurotransmitter 
release at presynaptic sites. In this context, the characterization of the mechanisms involved in 
the elementary release of ATP and the functional responses consequent to it assume particular 
interest. 
 
ATP release 
Many studies focussed on ATP-mediated transmission have been carried out by using 
exogenous ATP (for reviews, see Dunn et al., 2001; North, 2002) or heterologously expressed 
ATP receptors (Hollins and Ikeda, 1997; North, 2002; see section 2). As a consequence, our 
knowledge about ATP-mediated transmission between neurons and, in particular, about 
endogenous ATP release and the functional consequences of this release is quite limited.  
Actually, ATP has been shown to be a fast (non-metabotropic) synaptic transmitter in several 
parts of the brain, as it mediates a substantial fraction of both miniature and evoked excitatory 
post-synaptic currents in medial habenula (Edwards et al., 1992), as well as in hippocampus 
(Pankratov et al., 2006), thus making ATP release an important subject in view of the 
physiological role of ATP in the central nervous system. 
The release of endogenous ATP can be analyzed by several currently available methods, 
enabling quantification of its extracellular levels. The most widely used are the luciferin-
luciferase assay, which is a simple method based on the light-emitting reaction of luciferin with 
the ATP molecule, and the HPLC (high performance liquid chromatography), which can be 
used to monitor the release of radiolabelled purines (Lazarowski et al., 2003). These techniques 
are highly sensitive as they can detect ATP levels in the nanomolar range; nevertheless, they 
have a poor time resolution and, by measuring the ATP concentration of the bulk solution 
under examination, they are likely to severely underestimate the local ATP concentration near 
the cell surface. Recently, specific probes have been made available for measuring 
extracellular ATP, although their size is uncompatible with direct assays at synaptic sites (Dale 
et al., 2005; Llaudet et al., 2005). 
In addition to the direct study of ATP release, the physiological responses consequent to it 
should also be monitored for a better understanding of the mechanisms of ATP-mediated 
synaptic transmission, thus pointing to the need for a simple experimental model to study 
unitary events based on endogenously released ATP. To this aim, a reliable method to study 
endogenous ATP release and its effects at the level of the post-synaptic membrane could be the 
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use of a simple in vitro cell system, where the spontaneous (or evoked) ATP release could 
activate natively expressed ATP receptors on neighbour cells. In this respect, a suitable 
example of “ATP biosensor” with the above mentioned characteristics might be chromaffin 
cells or their relatives PC12 cells, because they contain ATP in their dense core vesicles 
(together with catecholamines; Njus et al., 1986) and also natively express ionotropic P2X2 
ATP receptors (Brake et al., 1994; see section 2). This issue was therefore investigated and the 
outcome is described in the first part of the results reported in the present thesis. 
 
2. ATP receptors  
Once released into the intercellular space, the action of ATP is mediated by ionotropic (P2X) 
or metabotropic (P2Y) receptors. These receptors are further classified into various subtypes, 
the P2X 1,2,3,4,5,6,7 (Ralevic and Burnstock, 1998; North, 2002) and the P2Y 
1,2,4,6,11,12,13,14 (Abbracchio et al., 2003; Boehm, 2003) receptors, operating via 
differential and specific mechanisms. 
P2Y receptors have a widespread distribution in both non-neuronal (gastrointestinal tract, 
heart, lung, liver, skeletal muscle) and neuronal tissues (spinal cord, brain, sensory neurons). 
They are activated by purine and pyrimidine nucleotides and are coupled to G proteins; their 
intracellular transduction mechanisms are extremely complex and involve several specific 
signalling pathways, including protein kinase C (PKC), phospholipase A2 (PLA2) and 
phospholipase C (PLC), depending on the specific P2Y receptor subtype involved (Ralevic and 
Burnstock, 1998; Burnstock, 2001; Ruan and Burnstock, 2003; Erb et al., 2006). 
 
P2X receptors 
In contrast to the relatively delayed, metabotropic response to ATP mediated by P2Y receptors, 
ionotropic P2X receptors account for the fast-developing response to ATP (Ralevic and 
Burnstock, 1998). P2X receptors are ATP-gated channels permeable to Na+, K+ and Ca2+, 
whose expression and distribution varies considerably in different tissues. For example, while 
P2X1 subunits are predominantly localized to platelets and smooth muscle cells, P2X5 to 
differentiating cells of muscle and skin, and P2X7 to glia and immune system cells, the other 
subunits are normally expressed by both neuronal and non-neuronal cells, implying an 
involvement of ionotropic ATP receptors in a large variety of physiological processes (Gever 
et al., 2006). The gene encoding the P2X2 subunit has been first cloned in the neuronally-
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derived PC12 cells: this protein has been then shown to have a widespread distribution, with 
different levels of expression, in both central and peripheral nervous systems (including 
neurons of the sensory and autonomic ganglia and of the dorsal horn of the spinal cord) in 
addition to many non-neuronal cell types (Gever et al., 2006). On the other hand, P2X3 
subunits are predominantly located in neurons, and they are specifically and abundantly 
expressed by small- and medium-sized cutaneous and visceral afferents from dorsal root 
ganglia (DRG) and trigeminal ganglia (TG), where these receptors are likely to play a 
fundamental role in nociceptive transmission and mechanosensory transduction (Burnstock, 
2000; Chizh and Illes, 2001; Petruska et al., 2000a; Ichikawa and Sugimoto, 2004; see also 
section 3). Primary afferents also express quite a high level of the P2X2 subunit; in this respect, 
it is interesting to note that these neurons have an embryological origin common to that of 
adrenomedullary chromaffin cells (from which PC12 cells are derived; Dunn et al., 2001; 
Tischler, 2002) and indeed share a relatively high level of expression of the P2X2 ATP receptor 
subunit (North, 2002). 
 
Structure and function of P2X receptors 
As already mentioned above, 7 different members of the P2X subunit protein family have been 
cloned, and they share 40-50% homology in aminoacid sequence (North, 2002). As 
exemplified in Figure 1, and in contrast to the “classical” four-transmembrane domain subunits 
building up ligand-gated ion channels, the P2X one has only two membrane-spanning 
hydrophobic domains separated by a large extracellular loop, while both the N- and C-
terminals are cytoplasmic (Vial et al., 2004). The extracellular loop has several conserved 
cysteines, which are likely to be implicated in disulfide bond formation, and specific aminoacid 
residues involved not only in agonist binding, but also in the receptor gating and deactivation 
(Vial et al., 2004; Zemkova et al., 2004). The intracellular portions of the P2X subunit show 
specific sites involved in receptor trafficking and phosphorylation by protein kinase C, which 
seems to be effectively involved in the functional modulation of this receptor (North, 2002; 
Vial et al., 2004; Stojilkovic et al., 2005). 
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Figure 1. 
Model of a representative P2X subunit (human P2X1). The subunit comprises two 
transmembrane domains, a large extracellular loop and cytoplasmic N- and C-terminal 
regions. Conserved aminoacids are indicated in red (residues identified from P2X2 and P2X4 
subunits are highlighted in green and orange background). The N-terminal domain comprises 
a consensus site for protein kinase C (PKC) phosphorylation, and residues variably involved in 
ATP-evoked responses modulation (in green). On the extracellular loop, several positively 
charged aminoacid residues are thought to be involved in the binding of the negatively 
charged ATP phosphates, while other residues are likely to interact with the adenine ring. The 
conserved cysteine residues are likely to form the disulfide bonds shown in the figure, whereas 
some non-conserved histidine residues are implicated in the regulation of some of the P2X 
subunits by cations. The C-terminal region show variable length among the different P2X 
subunits and includes a conserved motif involved in receptor trafficking (from Vial et al., 
2004). 
 
The functional form of a P2X receptor is made up by the co-assembly of usually three subunits, 
leading to the formation of dimers or multimers (North, 2002). The kinetic properties of the 
whole-cell ionic current mediated by these receptors during ATP application vary considerably 
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on the basis of the receptor subunit composition. Figure 2 A shows typical examples of the 
whole cell currents mediated by heterologously expressed homomers of cloned P2X subunits, 
and reveal one of the most striking features of the different subtypes of P2X receptors, namely 
their distinct desensitization properties (see below). While P2X1 and P2X3 receptor-mediated 
currents promptly decay during agonist application (that is, they desensitize rapidly), the other 
P2X receptors show little or no response decrease within the same time frame. 
Both homomeric and heteromeric P2X receptors have been found in neurons from different 
areas of central and peripheral nervous system and can be reproduced in heterologous 
expression systems (North, 2002). One of the most commonly found example of such a 
heteromerization is the P2X2/3 receptor, natively found in nodose ganglia neurons and primary 
afferents of DRG and TG (Dunn et al., 2001; North, 2002; Figure 2 B).  
A       B 
                
Figure 2. 
A. Top, examples of whole cell currents mediated by P2X receptors heterologously expressed 
in transfected HEK cells. Note the fast current fading (desensitization) during a 2 second-long 
ATP application (black bar, 30 µM; 1 mM only for P2X7) in P2X1 and P2X3 receptors. Bottom, 
longer ATP application induces slow desensitization also in P2X2 and P2X4 receptors (from 
North, 2002). 
B. Examples of ATP-evoked currents recorded from HEK cells expressing homomeric P2X2, 
homomeric P2X3 and heteromeric P2X2/3 receptors. Note that only P2X3 subunit-containing 
receptors are activated by the ATP analogue α,β-meATP (see text; from Ralevic and 
Burnstock, 1998). 
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Even if their distinct desensitization properties may help to distinguish the various P2X 
receptor types, the functional differentiation of these receptors is made difficult by the relative 
lack of agonists highly specific for each receptor type. Nevertheless, it is possible to some 
extent to discriminate between different P2X receptors on the basis of their differential pattern 
of responsiveness to agonists, sensitivity to antagonists and modulation by extracellular cations 
(Dunn et al., 2001; North, 2002; Roberts et al., 2006). For example, only P2X1 and P2X3 
subunit-containing receptors are activated by the stable ATP analogue α,β-meATP (with a 
potency similar to that of ATP), while homomeric P2X2 receptors are almost insensitive to this 
agonist (Figure 2 B, top). The lack of subunit-specific antagonists was improved only recently, 
with the availability of a selective antagonist for P2X3 subunit-containing receptors (5-[[[(3-
Phenoxyphenyl)methyl][(1S)-1,2,3,4-tetrahydro-1-naphthalenyl]amino]carbonyl]-1,2,4-
benzenetricarboxylic acid: A-317491; Jarvis et al., 2002), but highly selective agonists and 
antagonists for the other P2X subtypes remain to be developed. 
As mentioned above, primary sensory neurons represent the site where the expression of a 
specific subtype of ATP receptor subunit mediating the fast action of ATP (namely the P2X3 
one, as either a homomer or heteromerized with the P2X2 one) is specific and particularly 
strong. In view of this fact, and because of the involvement of P2X3 receptors in nociceptive 
input transmission (see section 3), the characterization of the structural and functional 
properties of P2X3 receptors is of particular interest and will be the focus of  large part of the 
experimental work reported in the present thesis. 
 
P2X3 receptor-mediated currents 
As already mentioned above, P2X receptors mediate a cationic current and are markedly 
permeable to Ca2+. The evaluation of the channel unitary conductance has been done by means 
of single channel recordings for several homomeric P2X receptor subtypes (North, 2002) and 
the one of P2X3 receptors seems to be close to 7 pS (Grote et al., 2005). Macroscopic currents 
obtained with whole cell patch clamp recordings have shown that activation of P2X receptors 
by ATP induces an inwardly directed, fast-developing current (see Figure 2 A). For instance, as 
far as native P2X3 receptors expressed on primary nociceptors are concerned, the peak current 
response to ATP can be achieved in about 10 ms (notwithstanding the considerable influence 
of agonist application speed; Burgard et al., 1999). In addition, inward rectification of currents 
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mediated by P2X receptors, including the P2X3 ones natively expressed by sensory neurons, 
has been observed (North, 2002; Giniatullin et al., 2003). 
 
Desensitization of P2X receptors 
Desensitization is classically defined as decrease or loss of biological activity following 
prolonged or repetitive stimulation (Katz and Thesleff, 1957), that is, in the case of P2X3 (and 
P2X1) receptors, the decline in the receptor-mediated current response during continuous 
exposure to the agonist. Receptor desensitization is, thus, an important “use-dependent” 
property, which controls receptor activity and modulates the physiological consequences of 
receptor activation. 
As already mentioned above, P2X receptors show different properties with respect to 
desensitization onset during agonist application (onset being measured as the speed at which 
the receptor-mediated current declines in the presence of the agonist; see Figure 2 and Figure 
3). Homomeric P2X3 receptors are particularly prone to this phenomenon, as they are readily 
desensitized by both ATP and its analogue α,β-meATP to a similar extent (North, 2002; 
Sokolova et al., 2004), while heteromeric P2X2/3 receptors show little or no desensitization in 
the presence of the agonist (Figure 2 B). Like for other ligand-gated ion channels, 
desensitization onset of P2X3 receptors depends on agonist concentration and even very low, 
subthreshold concentrations of extracellular ATP can induce receptor desensitization, via the 
process of “high-affinity desensitization”. In addition, desensitization onset of P2X3 receptors 
strongly depends on the nature of the agonist, as it varies considerably in the presence of 
different ATP analogues (Sokolova et al., 2004; Sokolova et al., 2006; Figure 3). 
Specific regions of the P2X receptor have been demonstrated to be involved in desensitization, 
including the extracellular loop, the transmembrane domains and the intracellular portions 
susceptible of phosphorylation by protein kinase C (PKC; Stojilkovic et al., 2005) or 
dephosphorylation by the phosphatase calcineurin (the last being particularly important for 
P2X3 receptors, via Ca2+ entry; King et al., 1997). 
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Figure 3. 
The half-time (t1/2) value of current decay during agonist application is an indication of 
desensitization onset. This value is a function of agonist concentration (desensitization onset 
stronger for higher agonist concentrations) and depends on the nature of the agonist. Figure 
shows the values of t1/2 for currents induced by ATP and its analogues 2-Me-SATP, α,β-meATP 
and β,γ-meATP on cultured rat DRG neurons (from Sokolova et al., 2006). 
 
Desensitization of P2X receptors is thought to correspond to an agonist-bound, closed state of 
the receptor; after agonist removal, receptors recover and are again available for activation 
(Rettinger and Schmalzing, 2003; Sokolova et al., 2006). In addition to desensitization onset, 
recovery from desensitization is an important functional feature of the receptor and could be 
considered as a component of a receptor “short term memory” (Cook et al., 1998). 
A characteristic functional feature of P2X3 receptors, in addition to their rapid desensitization 
onset, is their extremely slow recovery from desensitization, which is complete only after 
several minutes. Like desensitization onset, also recovery from desensitization is strongly 
influenced by the agonist nature because, for example, recovery of responses induced by the 
P2X3 receptor agonist α,β-meATP is faster than the one by ATP (Sokolova et al., 2004; 
Sokolova et al., 2006; Figure 4). 
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Figure 4. 
Recovery from desensitization can be quantified by a paired-pulse protocol (Sokolova et al., 
2004), in which two agonist pulses are spaced by different time intervals and the amplitude of 
the second pulse is expressed as a percentage of the first one. Recovery from desensitization 
strongly depends on the type of the agonist used. Plots are obtained from cultured DRG 
neurons (from Sokolova et al., 2006).  
 
P2X3 receptor recovery from desensitization is thus a complex phenomenon, influenced by a 
variety of factors, including receptor agonists themselves and, remarkably, extracellular 
polyvalent cations. Indeed, increase in extracellular Ca2+ levels accelerates P2X3 recovery in a 
dose- and time-dependent fashion, an effect also mimicked by  Gd3+ (Cook et al., 1998), while 
elevation of Mg2+ and extracellular Ca2+ depletion have the opposite effect (Giniatullin et al., 
2003). These properties imply that there should be specific sites on the P2X3 molecule (more 
likely in the extracellular portion) accounting for such a modulation, disclosing the possibility 
of identifying residues involved in the exogenous modulation of P2X3 receptors activity. In this 
respect, it is noteworthy that significant fluctuations of Ca2+ or Mg2+ levels take place during 
specific physiological or pathological conditions. Indeed, local Ca2+ levels can fluctuate at sites 
of elevated neuronal activity (Pumain et al., 1987; Stabel et al., 1990; Borst and Sakmann, 
1999). In addition, as far as pain-related conditions are concerned, tissue damage can dissipate 
the extracellular Ca2+ gradient existing in skin, thus exposing P2X3-expressing free endings of 
sensory neurons to altered Ca2+ levels (Menon et al., 1985). Conversely, a decrease in the level 
of cerebrospinal fluid free Mg2+ is present in patients suffering for migraine attacks and, 
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furthermore, the lowest Mg2+ levels are correlated with the most severe pain states (Lodi et al., 
2001). Taking into account the negative and positive effects of Ca2+ and Mg2+, respectively, on 
P2X3 receptor desensitization, the above mentioned observations could well fit with an 
involvement of P2X3 receptor desensitization in the transmission of nociceptive inputs related 
with these pathological states. 
 
Receptor desensitization is a fundamental property, which limits the receptor-mediated 
responses in situations when the agonist persists for a relatively long period of time. This is 
likely to be the case for ATP, when it is released in considerable amounts after tissue damage 
and could then act on P2X3 receptors on the peripheral processes of primary afferents for a 
long time (see section 3). Taking into account that P2X3 receptors have a relatively high 
permeability to Ca2+, that the increase in intracellular Ca2+ concentration is amplified by 
voltage-activated Ca2+ channels as a consequence of membrane depolarization, and that an 
excessive increase in intracellular Ca2+ levels might have toxic effects (Paschen, 2000), P2X3 
receptor desensitization may be considered a protective mechanism against the possibly toxic 
consequences of an intense and long-lasting exposure of these receptors to their physiological 
agonist. At the same time, since desensitization is a process having strong impact on the level 
of operation of P2X3 receptors, it could be considered as a suitable potential target for an 
efficient shaping of the activity of these receptors by exogenous modulators. 
 
3. P2X receptors in sensory neurons and the role of ATP in pain transmission 
The mRNA for diverse P2X subunits has been localised in sensory ganglion neurons, even if at 
different levels of expression (Vulchanova et al., 1998; Xiang et al., 1998; Dunn et al., 2001; 
Ruan et al., 2004). As already mentioned above, P2X3 receptors seem to be expressed almost 
exclusively by primary sensory afferents and in particular, as far as dorsal root ganglion (DRG) 
neurons are concerned, by the afferents of small- and medium-sized neurons from which small 
calibre fibres (Aδ and C) mediate the responses to noxious stimuli detected in the periphery 
(Millan, 1999; Hunt and Mantyh, 2001; Petruska et al., 2000a; Burnstock, 2001; North, 2002; 
Petruska et al., 2002; Figure 5). In addition to homomeric P2X3 receptors, also P2X2 subunits 
are expressed at a significant level by primary sensory neurons, and are supposed to be mainly 
part of heteromeric P2X2/3 receptors localized at peripheral and central terminals (Dunn et al., 
2001; North, 2002). Activation of peripheral P2X receptors triggers the excitation of 
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nociceptors by locally high levels of ATP, which can come from a wide variety of sources. In 
addition to being released from the cytoplasm of damaged cells, ATP can derive also from 
Merkel cells in the skin and tumour cells, as a consequence of tissue/skin injury or mechanical 
friction. Endothelial cells and platelets may be a source of ATP in several types of “vascular 
pain”, like migraine, angina and ischemic muscle pain. Sympathetic neurons also release ATP 
together with noradrenalin and are thought to be implicated in sympathetically-maintained 
chronic pain (Burnstock, 2001; North, 2004; Figure 5). As a consequence of stimulation, 
primary afferents themselves can release ATP at their central terminals. At this level, the 
endogenous, vesicular ATP release can influence both pre- and the post-synaptic sites, that is, 
it can act as a positive feedback mechanism to further enhance transmitter release from central 
terminals of primary afferents (Gu and MacDermott, 1997); in addition, it contributes to 
depolarization of second order neurons in the dorsal horn of the spinal cord, where functional 
P2X ATP receptors are expressed (Bardoni et al., 1997; Burnstock, 2001; Figure 5). Stimulus-
evoked ATP release and its action on P2X receptors at both pre-and post-synaptic sites could 
therefore be one of the sites where the modulation of transmission of nociceptive inputs from 
primary afferents to the central nervous system could take place. 
As indicated in Figure 5, the action of ATP continues also after its breakdown, when adenosine 
activates excitatory or inhibitory adenosine receptors in the peripheral and/or central terminals 
of primary afferents, accounting for multiple feedback mechanisms regulating neuronal 
excitability. 
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Figure 5. 
P2X ATP receptors play an important role in processing nociceptive information from the 
periphery to the second order neurons in the spinal cord (or in brainstem nuclei, in the case of 
TG neurons). Homomeric P2X3 and heteromeric P2X2/3 receptors expressed on the peripheral 
afferents of sensory neurons mediate the neuronal response to ATP released not only from 
damaged cells, but also by other peripheral sources. Activation of P2X receptors leads to the 
depolarization of primary afferents and the consequent glutamate release on second order 
neurons. ATP itself is also released by central terminals of sensory neurons and acts at both 
pre- and post-synaptic sites. At the post-synaptic site it activates P2X receptors (containing the 
P2X2, P2X4 and P2X6 subunits) on second order neurons, thus contributing to their excitation, 
while at pre-synaptic level it acts as a positive feedback mechanism to enhance glutamate 
release via activation of P2X3 receptors. The breakdown product of ATP, adenosine, can act 
on its own receptors at both peripheral and central terminals of sensory neurons, inhibiting or 
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potentiating neuronal excitation depending on the receptor present (A1 or A2; from Burnstock, 
2001). 
 
At a higher system level, the specific expression of ionotropic P2X ATP receptors in primary 
sensory neurons is documented by many reports directly demonstrating the acute pain-inducing 
action of ATP. Indeed, ATP elicits pain when applied to the skin (Coutts et al., 1981) as well 
as after intracutaneous or intramuscular injection in humans (Hilliges et al., 2002; Mork et al., 
2003). Similarly, animal studies have shown dose-dependent nocifensive behavior induced by 
administration of ATP or its analogues (Bland-Ward and Humphrey, 1997; Hamilton et al., 
1999; Jarvis et al., 2001). ATP also directly excites primary afferent neurons in both in vivo 
and in vitro preparations: for example, application of ATP or its analogues to joint nociceptors 
(Dowd et al., 1998) or skin nerves (Hamilton et al., 2001) causes excitation of a subset of A 
and C afferents. Further confirmation of the algogenic action of ATP and of the specific 
involvement of P2X3 receptors in pain transmission comes from the observation that 
intrathecal administration of the P2X3 receptor agonist α,β-meATP has pro-nociceptive effects 
(Driessen et al., 1994) and that P2X3 knockout mice show a markedly reduced sensitivity to 
certain noxious stimuli (Cockayne et al., 2000). 
In addition to their role in acute pain, P2X3 receptors undergo plastic changes during chronic 
painful conditions, as their expression is strongly enhanced in DRG neurons during 
inflammation or neuropathic pain (Novakovic et al., 1999; Xu and Huang, 2002): this provides 
the rationale for investigating the possible modulation of P2X3 receptor function by different 
factors over a wide range of time frames. 
The induction/transmission of several features of nociception via P2X3 receptors on DRG 
neurons is well established. Nevertheless, relatively little is known about the pain-related 
mechanisms involving P2X3-mediated excitation of primary afferents of the trigeminal 
ganglion (TG) neurons, especially in chronic pain states. For instance, during headache attacks, 
pain is believed to be due to repetitive firing of nociceptive trigeminal ganglion neurons. 
Trigeminal nerve terminals possess high density of P2X3 receptors that mediate sensitization of 
trigeminal sensory neurons (for example during persistent dental pain; Hu et al. 2002); such 
cells may be activated by locally released ATP and may also release ATP as excitatory 
transmitter on central neurons within the trigeminal nucleus of the mesencephalon (Khakh and 
Henderson, 1998). It seems thus feasible that several pain states of cranial origin, including 
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headache, are at least in part mediated by P2X3 receptors, and this represents an interesting 
topic for further investigation. 
 
4. Modulation of P2X3 receptors activity 
In addition to extracellular cations (like Ca2+; see above), P2X receptor activity can also be 
modulated by intracellular factors, some of which have been identified. The N-terminal region 
of all P2X receptors contains a consensus site for protein kinase C (PKC), but it is feasible that 
receptors may also be directly phosphorylated at other intracellular sites, or regulated indirectly 
via phosphorylation of accessory proteins (Vial et al., 2004; Roberts et al., 2006). For instance, 
as far as P2X3 receptors are concerned, ATP-evoked currents mediated by heterologously 
expressed P2X3 or P2X2/3 receptors can be potentiated by acutely-applied substance P and 
bradykinin, with an action dependent on the PKC-mediated phosphorylation of this conserved 
consensus site (Paukert et al., 2001). 
In addition to phosphorylation, P2X receptors can be regulated by the interaction with other 
receptor types as, for example, P2X3 receptors show occlusion with GABA currents and the 
P2X2 ones can directly interact with serotonin (5-HT) receptors (Sokolova et al., 2001; Boue-
Grabot et al., 2003). Most probably other, not yet identified intracellular regulatory 
mechanisms are likely to be involved in the modulation of P2X receptor activity. In relation to 
this, one fundamental topic of interest concerns the identification of the extracelluar substances 
triggering this modulation, namely the endogenous (or exogenous) factors which could 
influence the physiological response mediated by P2X receptors. One attractive hypothesis is 
that specific nociception-modulating substances, whose levels are elevated during pathological 
states (like, for example, inflammatory reactions), could potentiate the responses mediated by 
ATP receptors expressed by nociceptors. For instance, long-term inflammatory conditions, like 
those induced by complete Freund’s adjuvant injection, induce a markedly increased response 
of DRG neurons to ATP application (Xu and Huang, 2002), a phenomenon in accordance with 
the enhancement of nocifensive behavior by ATP injection in rats after carrageneenan-induced 
inflammation (Hamilton et al., 1999). It seems likely that some of the soluble factors produced 
during such pathological states could contribute to the modulation of the activity of P2X3 
receptors and of other pain-related receptors endogenously expressed by sensory neurons (see 
below). 
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Inflammation and Nerve Growth Factor (NGF) 
It is now well established that Nerve Growth Factor (NGF), in addition to being a survival 
factor for peripheral neurons during development, subserves different functions in the adult 
(Sofroniew et al., 2001). In particular, NGF is among the substances whose levels are 
significantly increased for a relatively long time in a number of pathological states, particularly 
in inflammation (Sah et al., 2003; Pezet and McMahon, 2006). In vivo, NGF has a pro-algesic 
action as its administration induces pain and hyperalgesia, an effect which can be reversed by 
anti-NGF antibodies. Accordingly, in vitro studies have demonstrated that acute or chronic 
administration of NGF to DRG neurons increases their sensitivity to capsaicin, noxious heat 
and acidic pH, it increases the expression of TTX-sensitive and -insensitive Na+ channels (thus 
increasing neuronal excitability), and also enhances the production of neuropeptides like 
substance P (SP) and calcitonin gene-related peptide (CGRP; Pezet and McMahon, 2006). 
Even if the basal levels of NFG are quite low, various cell types, including epithelial cells, 
fibroblasts, keratinocytes, Schwann cells and macrophages are significant sources of NGF in 
inflammatory conditions (Pezet and McMahon, 2006); sensory ganglion neurons might also 
contribute to NGF synthesis, although this issue is controversial (Wetmore and Olson, 1995; 
Jacobs and Miller, 1999). 
Both low- and high-affinity receptors for NGF exist (p75 and TrkA) and they are expressed by 
a specific subtype of nociceptive primary sensory neurons in a developmentally-regulated 
fashion. Activation of TrkA receptors triggers several signalling pathways, including the 
MAPK pathway, phosphatidyl inositol-3 kinase and phospholypase C; this can lead, in turn, to 
the sensitization of nociceptor responses to noxious stimuli cited above via both transcriptional 
and post-translational mechanisms (Pezet and McMahon, 2006). 
Despite the quite well established role of NGF in inflammatory pain, information about the 
long-term effects of NGF as an “inflammatory mediator” specifically on ionotropic ATP 
receptors of sensory neurons is relatively scanty. In particular, there are only few studies which 
analyzed in detail the possible modulatory action of NGF on P2X3 receptors, with basically 
different experimental protocols for NGF administration (chronic exposure of cultured DRG 
neurons or osmotic minipumps fitted to in vivo animals; Bevan and Winter, 1995; Ramer et al., 
2001). No effect has been found in receptor function after exposure to NGF in the former case, 
while an enhancement of P2X3 expression in primary sensory neurons has been observed in the 
latter.  
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One interesting point in the action of NGF is its time-course. Indeed, while acutely applied 
NGF via TrkA activation might directly phosphorylate pre-existing intracellular targets, over 
the longer term NGF could exert a more global influence on neuronal function, possibly by 
regulating the expression of releasable substances (SP, CGRP), but also, and more 
interestingly, nociceptor-specific ion channels like P2X3 receptors. In this respect, for example, 
NGF has been suggested quite a long time ago to be a hyperalgesia-provoking factor in 
migraine (Sandler, 1995), thus implying its action on TG nociceptors. Indeed, NGF levels have 
been found to be increased in the cerebrospinal fluid of subjects experiencing headache attacks 
(Sarchielli et al., 2001), thus raising the need to investigate the effects of NGF on P2X3 
receptors not only on DRG nociceptors, but also on the TG ones. 
 
Serotonin (5-HT) 
Serotonin (5-hydroxytryptamine; 5-HT) is a common neurotransmitter in the central nervous 
system and it contributes to processing and modulating pain transmission at the central level, 
via inhibition of dorsal horn neurons in the spinal cord through descending inhibitory 
pathways. In contrast to its central effects, the peripheral action of 5-HT is often pro-algesic, as 
this substance is considered to be an inflammatory mediator in the periphery (Millan, 1999; 
Sommer, 2004). Indeed, 5-HT has been reported to elicit pain in certain conditions, but 
especially, and more consistently, to enhance the pro-nociceptive action of other inflammatory 
mediators (Sommer, 2004). 
5-HT can be released in considerable amounts by platelets, mast cells, endothelial cells and 
serotonergic neurons surrounding the microcirculation and its levels are increased in several 
models of inflammatory pain and tissue injury; increased serum levels of 5-HT during migraine 
attacks have also been reported by several clinical studies (Ferrari et al., 1989; Ribeiro et al. 
1990; Sommer, 2004). 
A number of 5-HT receptor types have been detected in both DRG and TG primary sensory 
neurons, at the level of protein or mRNA (Lazarov, 2002; Sommer, 2004). Among them, the 
activation of ionotropic 5-HT3 receptors leads to direct excitation of primary afferents, while 
an excitatory or inhibitory effect on neuronal activity can be obtained by activating the other 5-
HT receptors subtypes, which are metabotropic and operate via a multiplicity of signal 
transduction mechanisms (Raymond et al., 2001). For example, while 5-HT3 receptor 
activation directly excites TG neurons by evoking an inward current (Hu et al., 2004), 5-HT1B/D 
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receptor subtypes have an inhibitory action (via inhibition of adenylate cyclase) and are indeed 
the target of 5-HT1 receptor agonists developed for migraine treatment (triptans; Goadsby et 
al., 2002). 
5-HT modulates the activity of several receptors on primary afferent neurons. Application of 5-
HT to visceral nociceptors acutely and robustly enhances the neuronal responsiveness mediated 
by TRPV1 receptors, which are among the main pain transducers (see section 5; Sugiura et al., 
2004). As far as P2X receptors are concerned, an inhibitory cross-talk between the ionotropic 
5-HT3 and P2X2 receptors has been found in enteric neurons (Boué-Grabot et al., 2003), while 
no acute effects of 5-HT on the activity of P2X3 receptors has been found (Nakazawa and 
Ohno, 1997). These findings thus suggest the need for elucidating the possible role of 5-HT in 
shaping the responses of primary afferents, and in particular of nociceptors, to several 
excitatory stimuli, particularly in relation to long-lasting exposure to 5-HT. Within this 
framework, the possibility that such a modulation could take place also on P2X3 receptors 
seems plausible at the level of both DRG and TG neurons, in view of the high level of 
expression of these receptors and the likelihood of marked fluctuations in the local levels of 5-
HT in certain physiological or pathological conditions. 
 
Calcitonin Gene-Relate Peptide (CGRP) 
A substantial fraction of nociceptors of DRG and TG synthesizes and releases the 
neuropeptides substance P (SP) and calcitonin gene-relate peptide (CGRP; Hunt and Mantyh, 
2001; Durham and Russo, 2002). CGRP is a 37 aminoacid peptide generated by the alternative 
splicing of calcitonin gene transcripts; two different CGRP isoforms exist, α and β, and the α 
one is primarily expressed by sensory neurons (Arulmani et al., 2004). The receptors for CGRP 
have been identified in various tissues, including the cardiovascular system (where CGRP has 
a vasodilatory effect) and, notably, in several regions of the central and peripheral nervous 
system, including TG and DRG neurons themselves (Van Rossum et al., 1997; Segond von 
Banchet et al., 2002). CGRP binds to metabotropic receptors belonging to a family of proteins 
in which a seven-transmembrane domain, G protein-coupled receptor binds to two accessory 
proteins (RAMP -receptor activity modifying protein- and RCP -receptor component protein-) 
in order to form functional receptors. The resulting CGRP-activated receptor works via an 
intracellular pathway involving the activation of adenylate cyclase and leading ultimately to 
the accumulation of cyclic AMP (Poyner et al., 2002; Arulmani et al., 2004). 
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CGRP seems to be not directly algogenic, since peripheral administration of CGRP does not 
produce hyperalgesia (Chu et al., 2000; Weidner et al, 2000). Nevertheless, the synthesis and 
release of CGRP from TG neurons has been found to be significantly increased by 
depolarization or by treatment with a mixture of substances involved in inflammation and, in 
full agreement with these findings, CGRP levels are increased during inflammation and in 
various forms of headache, including migraine. This increase is probably a consequence of 
enhanced release by activated TG afferents innervating the brain microcirculation at the 
meningeal level. In this respect, it is worth noting that during a migraine attack the levels of 
CGRP are significantly augmented, while those of SP are not (Durham and Russo, 2002; 
Edvinsson and Uddman, 2005). Furthermore, CGRP levels often correlate with the time course 
and the intensity of pain, suggesting a direct relationship between CGRP and migraine (Juhasz 
et al., 2003; Juhasz et al., 2005). A further confirmation of the pro-nociceptive role of CGRP in 
specific pathological states comes from the growing amount of data demonstrating the 
effectiveness of CGRP receptor antagonists in the treatment of migraine pain (Olesen et al., 
2004; Edvinsson, 2005). 
CGRP seems to have no direct, acute effect on the activity of meningeal TG nociceptors (Levy 
et al, 2005); however, it can enhance the release of excitatory aminoacids from primary 
afferent neurons (Kangrga et al., 1990) and can also cause a slight increase in the intracellular 
calcium level in a subset of DRG neurons (Segond von Banchet et al., 2002). In view of the 
fact that CGRP can be synthesized and released by peripheral and, probably, also central 
afferents of sensory TG neurons (Storer et al., 2004; Fischer et al., 2005; Strassman and Levy, 
2006), and that the same neurons can express receptors for CGRP, it seems likely that sensory 
afferents might be exposed to relatively large local amounts of this neuropeptide and could 
then be important targets for the CGRP action. Within this framework, the highly expressed 
P2X3 receptors might be among the favorite candidates for CGRP-mediated modulation. 
 
Notwithstanding the role of the above discussed substances, there is, of course, plenty of other 
substances whose levels fluctuate significantly in specific physiological or pathological 
conditions and which could then be tested for their ability to modulate P2X3 receptors on 
primary nociceptors (Millan, 1999). A detailed examination of the effects of these compounds 
is outside the scope of the present thesis. 
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5. TRPV1 receptors as “prototypical” pain receptors 
The expression of transient receptor potential vanilloid 1 (TRPV1, also known as VR1) 
receptors is widespread in several areas of the nervous system, but it is particularly strong in 
both DRG and TG nociceptors, in which they are considered to be among the “prototypic” 
detectors of noxious inputs (Julius and Basbaum, 2001), in addition to P2X3 receptors. It is 
interesting to note that the relation between TRPV1 and P2X3 receptors expression may 
considerably vary. Indeed, while P2X3 receptor-expressing DRG neurons are usually 
capsaicin-responding (that is, they have functional TRPV1 receptors; Petruska et al., 2000b; 
Petruska et al., 2002), the colocalization of P2X3 and TRPV1 receptors in TG neurons 
innervating skin and tooth pulp is significantly lower (Ichikawa and Sugimoto, 2004). 
TRPV1 receptors are activated by a wide variety of stimuli, both exogenous (noxious heat, 
capsaicin) and endogenous (protons, anandamide, lipoxygenase products, N-arachidonoyl 
dopamine) and they mediate a non-selective cationic current with particularly high Ca2+ 
permeability (Tominaga and Caterina, 2004). 
The role of TRPV1 receptors in the transmission of selective nociception modalities comes 
from studies of TRPV1-deficient mice, whose behavioral reaction to capsaicin and acute heat 
is strongly attenuated and the response of primary sensory neurons to the same stimuli is 
severely impaired (Caterina et al., 2000). In addition, TRPV1 receptors have been shown to be 
particularly prone to acute sensitization by a number of substances known to be key 
inflammatory mediators, like NGF, bradykinin and lipoxygenase products (Julius and 
Basbaum, 2001; Tominaga and Caterina, 2004). In view of this fact, TRPV1 receptor 
expression and activity might be considered as markers for a specific subtype of sensory 
neurons, and their activation by exogenous stimuli (e.g., capsaicin) could be a useful tool to 
test the possible modulatory effects of pain-related substances. 
 
6. Counteracting excitation: GABAA receptors as possible targets for modulation 
Primary sensory neurons express not only receptors which physiologically mediate excitation 
(e.g. P2X3 and TRPV1), but also receptors exerting an opposite function in physiological 
conditions, among which ionotropic GABAA receptors are representative elements (White, 
1990; Ma et al., 1993; Lazarov, 2002). Indeed, a fundamental check-point in the processing of 
peripheral inputs in vivo is related to the activity of GABAergic interneurons located in the 
dorsal horn of the spinal cord. Sustained and relatively long-lasting GABA release activates 
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GABAA receptors on the central terminals of sensory neurons and might be responsible for 
presynaptic inhibition due to primary afferent depolarization (PAD; Frank and Fuortes, 1955; 
Dickenson et al., 1997; Rudomin and Schmidt, 1999). Actually, GABAA receptors expressed 
by primary afferent neurons show the classical molecular structure of these receptors, that is, a 
developmentally-regulated combination of specific GABAA subunits (Ma et al., 1993). 
Nevertheless, in contrast to neurons of the central nervous system, GABAA receptors expressed 
by sensory neurons mediate efflux of chloride ions and, therefore, their activation has a 
depolarizing effect; depolarization of central terminals can then either block the invasion of 
afferent terminals by action potentials or reduce action potentials amplitude, thus leading to a 
decrease in neurotransmitter release (MacDermott et al., 1999; Rudomin and Schmidt, 1999).  
From the functional point of view, there are several indications of an involvement of 
GABAergic transmission in the modulation of nociceptive inputs. Among them, it is 
interesting to note that GABA ionotropic (and metabotropic) receptors seem to contribute to 
the inhibitory control of nociceptive transmission directly at the level of the spinal cord 
(Dickenson et al., 1997). In addition, GABA receptors seem to directly interact with 
“excitatory” receptors, since a quite strong, mutually inhibitory interaction takes place between 
GABA receptors and ionotropic, “pain-mediating” P2X3 receptors (Sokolova et al. 2001; 
Sokolova et al., 2003). These findings suggest that GABAA and P2X3 receptors might be 
differentially regulated in certain conditions, as the activity of P2X3 receptors could facilitate, 
while that of the GABAA ones could inhibit, the transmission of sensory input by primary 
afferent neurons. In this context, the same modulatory factors which could potentially 
influence the activity of P2X3 receptors (see above) might also exert an effect on GABAA 
receptors. In this respect, both the ability of the receptor to respond to its agonist and the 
desensitization of this response are key factors characterizing receptor activity. In particular, 
desensitization of GABA-induced responses could provide an indication of the persistence of 
the GABA-mediated action and could then be as important as P2X3 receptors desensitization 
for shaping the transmission of nociceptive inputs. 
 
7. Cell cultures as a model to study ligand-gated ion channels 
The functional properties of primary sensory neurons and their receptors are usually 
investigated by means of a wide variety of experimental models, both in vivo and in vitro. 
Several in vivo animal models have been developed and characterized for modelling specific 
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sensory modalities, including nociception, particularly in rodents (see, for a few representative 
examples, Pezet and McMahon, 2006). The use of these models offers the advantage of a 
situation closer to the human physiological/pathological condition, and it is therefore a 
fundamental step in the comprehension of the basic mechanisms underlying the function of 
sensory systems and for the development and validation of new possible strategies for their 
modulation. As far as the modulation of receptors involved in nociceptive input transmission is 
concerned, it is indeed possible to reproduce in rodents various painful states observed in 
humans (e.g. inflammatory or neuropathic pain states; see Pezet and McMahon, 2006). 
The lack of suitable animal models for certain pain syndromes requires the use of strictly 
controlled in vitro paradigms in order to dissect the fundamental properties of the basic 
processes. A particular case, in which this situation is of special importance, is represented by 
migraine pain syndromes, since no reliable test for detecting and measuring the intensity of 
migrainous pain in in vivo animal models are available, and an in vitro system based on 
isolated TG neurons seems to be an appropriate tool to study some aspects of the 
pathophysiological mechanisms underlying nociception. 
Therefore, notwithstanding the importance of in vivo animal models, simpler systems are 
useful, in which the intrinsic nature of the basic elements building up more complex pathways 
can be analyzed without the interference of the intricate regulatory connections operating in the 
intact animal. 
 
One possible approach to the study of the functional aspects of neurotransmitter release and 
receptor-operated ion channels activity is the direct recording of the receptor response to its 
agonist on isolated cells expressing the receptor, by means of patch clamp recordings or 
calcium imaging techniques. One simple experimental model to do this is the study of the 
responses mediated by receptors endogenously expressed by established cell lines. For 
instance, PC12 cells are known to express a high amount of P2X2 receptors (Brake et al., 1994) 
and can be used for this purpose. Alternatively, the receptor under investigation can be 
expressed in an appropriate heterologous system: for example, as far as ionotropic ATP 
receptors are concerned, they can be efficiently expressed in Human Embryonic Kidney (HEK) 
cells, that lack endogenous P2X3 receptors and show good expression ability (Vulchanova et 
al., 1997; North, 2002). Nevertheless, care should be taken to avoid concurrent activation of 
metabotropic P2Y ATP receptors (expressed by these cells; Fischer et al., 2003) by ATP 
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application, a result attainable by means of ATP analogues selective for P2X3 receptors (α,β-
meATP; North, 2002).  
 
The next step in the study of receptor activity would be its characterization in the native 
system, where it is physiologically expressed. In order to systematically dissect the basic 
properties of primary sensory neurons in terms of receptor expression, function and 
modulation, several in vitro preparations are used as model systems, including intact DRGs 
(e.g. Stebbing et al., 1998), skin-nerve preparations (e.g. Caterina et al., 2000; Hamilton et al., 
2001), acutely dissociated neurons (e.g. Petruska et al., 2000a, 2000b; Petruska et al., 2002) 
and primary cultures of sensory neurons (e.g. Cook et al., 1997; Caterina et al., 2000; Durham 
and Russo, 2003). 
One important aspect related to the use of in vitro systems and, in particular, neuronal cultures, 
is the assumption that the receptors expressed on the neuronal soma mirror the receptor 
population on the terminals of the same cells. Indeed, functional and histological studies 
indicated that the key receptors involved in the transmission and modulation of nociceptive 
inputs are expressed at the level of the fine peripheral and/or central terminals of DRG and TG 
neurons (e.g. GABAA, P2X3 and TRPV1, receptors; Rudomin and Schmidt, 1999; Dunn et al., 
2001; Tominaga and Caterina, 2004). The study of these receptors at the somatic level can 
overcome the difficulty of direct access to these fine terminals. The assumption of a receptor 
expression pattern on the neuronal soma mirroring the receptor populations on the primary 
afferent terminals seems to be correct, since, for example, functional P2X3, TRPV1 and 
GABAA receptors are expressed also on the soma of primary sensory neurons in intact ganglia 
or in acutely dissociated neurons (e.g. Petruska et al, 2000a; Labrakakis et al., 2003; Ichikawa 
and Sugimoto, 2004). Hence, somatic receptors expressed by sensory neurons in culture have 
been extensively used (e.g. Caterina et al., 2000; Sokolova et al., 2001) and sensory neurons in 
culture are a suitable model for studying the properties of a variety of receptors and channels 
and their modulation. In this respect, one fundamental point is that the experimental model 
selected to explore a specific topic should be first fully characterized in its basal, naive 
condition. In particular, if neuronal cell cultures are chosen for investigating the properties of a 
particular receptor, possible differences with respect to the native tissue condition should be 
taken into account and characterized. Additionally, if the interest is in the possible long-term 
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effects of a modulatory factor, the intrinsic temporal development of the model culture in terms 
of cell viability and patterns of receptor expression/function should not be neglected. 
 
AIMS 
 
The findings reported in the previous sections illustrate that various features concerning the 
mechanisms of action of ATP and its receptors, the physiological actions of pain-signalling 
TRPV1 receptors and that of the inhibitory GABAA receptors on sensory neurons have been 
well characterized. Nevertheless, many aspects of the activity of these receptors and the factors 
contributing to their modulation are still not completely understood. The work reported in this 
thesis aims at contributing to the understanding of the functional features of the above 
mentioned receptors. In particular, the experimental work addresses the following issues: 
1- ATP is physiologically released by neuronal terminals and can act both pre-and post-
synaptically: could PC12 cells (containing ATP in their vesicles and endogenously 
expressing P2X2 receptors) serve as a simple and cheap in vitro model system to study 
endogenous ATP release and the electrophysiological responses consequent to it? 
2- How do P2X and TRPV1 receptors in trigeminal ganglia relate to those expressed in 
culture? Are they functional and stable in culture? Are rat or mouse TG neurons in culture 
equivalent models to study these receptors? Can P2X and TRPV1 receptors be positively or 
negatively modulated in culture, in particular by NGF or 5-HT? 
3- P2X3 receptors of primary afferent, nociceptive neurons are among the main pain-
transducer receptors and their activity is potently influenced by their strong desensitization: 
what molecular determinants of P2X3 receptors contribute to their desensitization 
properties? 
4- TG neurons in culture could be used to mimic the conditions which they are expected to 
meet during an attack of migraine: what are the effects of calcitonin gene-related peptide 
(CGRP) on their P2X3 and TRPV1 receptors? 
5- NGF has been implicated in the pathogenesis of inflammatory pain: if it could modulate 
P2X3 and/or TRPV1 receptors, what might be its effects on the physiologically inhibitory 
GABAA receptors? 
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In this thesis, all these issues will be critically discussed on the basis of the original 
experimental data obtained during the PhD course, and linked to the current knowledge of the 
molecular and functional properties of P2X, TRPV1 and GABAA receptors. 
 
MATERIALS, METHODS AND RESULTS 
 
See enclosed papers.  
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DISCUSSION 
 
The present thesis has provided new elements for the understanding of ATP-mediated 
transmission, and of the functional properties of ionotropic receptors for ATP (and for other 
transmitters) on sensory neurons. In particular, it has described PC12 cells as an in vitro model 
for the study of ATP release-mediated events, and cultures of trigeminal ganglion (TG) 
neurons in culture as a system in which the modulatory effect of putative algogenic substances 
(NGF, 5-HT, CGRP) can be effectively assessed. 
The findings reported in this thesis have been already discussed in the individual papers; in 
addition, a more comprehensive discussion and interpretation of the results obtained from the 
experimental work will be provided below, in relation to their possible physiological 
implications and the most recent findings in the field. 
 
1. Fast, quantal-like, P2X2 receptor-mediated currents induced by vesicular ATP 
release in undifferentiated PC12 cells  
A fundamental issue in the study of synaptic transmission is the understanding of the 
mechanisms involved in transmitter release and its effect on the activity of its post-synaptic 
receptors. In this framework, the study of the elementary release events and of the spontaneous 
(miniature) or evoked post-synaptic currents assumes particular interest, because it provides 
information about both the responsiveness of the post-synaptic element and the amount of 
transmitter released by the pre-synaptic one. 
Unitary events occurring at synapses could be effectively mimicked by a system in which the 
transmitter of interest (ATP) is released at one side of the cell-cell contact and a fast, ionotropic 
receptor for it (P2X) is expressed at the other side. PC12 cells store ATP together with 
catecholamines in their releasable dense core vesicles (DCVs; Njus et al., 1986) and express 
P2X2 receptors (Brake et al., 1994), therefore providing a potentially useful model to 
investigate the properties of purinergic fast signalling involving P2X2 receptor. 
PC12 cells and chromaffin cells are classical models for the study of exocytosis (Tischler, 
2002; Martin, 2003) and PC12 cells are able to differentiate toward a neuronal phenotype in 
response to NGF treatment (Tischler, 2002). Nevertheless, since NGF also exerts many other 
actions in terms of cell survival, development and neuronal receptor plasticity (Sofroniew et 
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al., 2001; Pezet and McMahon, 2006), it seems likely that NGF-untreated, undifferentiated 
PC12 cells are a more reliable model for the study of the system in its basal conditions. 
 
Purinergic nature of STICs  
The work reported in the first part of this thesis illustrates that clustered PC12 cells show small 
transient inward currents (STICs) following application of either ATP or KCl. 
P2X2 receptors activated by ATP released from neighbour cells seem to be the origin of STICs, 
because these events are abolished by superfusion with a Ca2+-free extracellular solution and 
by the P2X receptor antagonist PPADS. 
The conclusion that STICs are due to ATP release from DCV also finds several points in its 
favour and, in this respect, the delayed appearance of STICs relative to the triggering input is 
an interesting issue. PC12 cells grown in the absence of NGF show a relatively long latency of 
catecholamine (and ATP) secretion from DCVs (seconds; Ninomiya et al., 1997). This fact is 
in full agreement with the reported 3-4 seconds latency of STICs, providing an additional, 
circumstantial evidence that STICs are due to ATP released from DCV. In addition, the single 
peak observed in the distribution of STICs amplitude and decay time suggests a mainly 
monoquantal ATP release. Consistently with the DCV origin of quantal ATP release, 
Grandolfo and Nistri (2005) have reported that the number of both total and perimembrane 
DCVs of PC12 cells falls after a pulse of ATP or KCl, thus indicating DCVs depletion 
following stimuli which are known to induce the appearance of STICs. 
 
STICs,  maturation and clusterization of PC12 cells 
One necessary condition for the appearance of STICs is cell clusterization. Indeed, in only a 
few cases (5%) STICs have been detected in isolated cells and the scheme described (fig. 9 in 
the original paper) shows that the cells closely surrounding the patched one are likely to be the 
ATP source. The perfusion system employed in the experiments (multibarrel rapid solution 
changer; see Methods in the enclosed paper) is actually a suitable device for obtaining STICs 
after application of the triggering substances (ATP or KCl), because each glass capillary can be 
positioned  quite close to a cell cluster and, owing to an internal capillary diameter of about 
0.58 mm, these substances are simultaneously applied to the whole cell cluster. Consistently 
with a mechanism dependent on cell clusterization, vesicular ATP release and P2X2 receptor 
activation, the appearance of STICs is correlated with time in culture (that is, with the number 
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and size of cell clusters), its Ca2+ response to a depolarizing KCl pulse (which is likely to 
trigger DCVs exocytosis) and the ability to respond to ATP. All these parameters gradually 
grow with time in culture. KCl responses show a strong decrease after the sixth day in culture, 
while ATP responsiveness continues to grow. Culture ageing, accompanied by a possibly 
differential temporal decay pattern for the activity of voltage-activated Ca2+ channels 
(contributing to the Ca2+ response to KCl pulses) and of ATP-activated P2X2 receptors might 
account for this phenomenon. 
The ability of PC12 cells to respond to ATP and its relation to cell maturation in culture is an 
interesting point, as STICs occurrence is very low in the first days after plating, when the 
current response to 1 mM ATP is also low. There are at least five different mechanisms which 
might account for the low probability of observing STICs in the above mentioned conditions 
(some of which have been already discussed in the enclosed paper). First, there could be no 
exocytosis of DCVs, for instance because of a small readily releasable DCVs pool: this is 
probably not the case, because sustained evoked exocytotic activity has been reported from 
acutely plated PC12 cells (Ninomiya et al., 1997). Second, DCVs might be loaded with a 
smaller amount of ATP, for example because of a weaker H+ gradient across the vesicle 
membrane or a lower activity of the vesicular ADP/ATP translocase (both mechanisms being 
suitable systems for vesicular ATP loading; Pankratov et al., 2006). Because the H+ 
electrochemical gradient usually drives the carrier-mediated neurotransmitter uptake into 
vesicles, it would be interesting to monitor the amount of catecholamines loaded in DCVs of 
PC12 cells at different time points in culture, in order to investigate a possible, parallel time-
dependent catecholamine loading. The third possibility is that, in the first days in culture, ATP 
could be effectively released, but the density of P2X2 receptors is so low that the resulting 
STICs have very low amplitude, which could be masked by current baseline noise (this would 
be in agreement with the lower responsiveness to exogenously applied ATP). Then, the low 
number of contacts between neighbouring cells could simply make the occurrence of DCV 
exocytosis in the narrow intercellular space less probable. Finally, the intracellular Ca2+ 
increase might be a limiting factor; in this respect, it would be interesting to characterize the 
possible developmentally regulated expression and function of Ca2+ channels in PC12 cells, 
which might account for a reduced DCVs exocytosis. The finding that isolated cells, even 
when patched without Ca2+-buffers in the pipette solution, do not show STICs (with only few 
exceptions) well fits with a possible developmentally regulated activity of both ATP-releasing 
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machinery and P2X2 receptors. This phenomenon, thus, depends on intercellular contacts, in a 
way similar to the already reported adhesion-dependent maturation and plasticity of synapses 
(Gerrow and El-Husseini, 2006). 
 
PC12 cells as a model system to study ATP-mediated events  
Miniature and evoked unitary currents induced by release of endogenous ATP have been 
described in acute slices of habenula and spinal cord (Edwards et al., 1992; Bardoni et al., 
1997) and, more recently, in hippocampal slices and from dissociated stellate neurons 
(Pankratov et al., 2006; Tompkins and Parsons, 2006). These preparations can thus serve as 
reliable systems for the study of unitary events mediated by endogenous ATP release. STICs 
detected in PC12 cells could provide an additional (and maybe simpler) model system in which 
these events and their underlying mechanisms can be investigated. 
PC12 cells possess a relatively small DCVs readily releasable pool (Martin, 2003) with respect 
to chromaffin cells and are then less efficient in terms of DCVs exocytosis. Nevertheless, if the 
focus is on P2X receptor-mediated events, native chromaffin cells are not a suitable model, 
because no ATP-mediated currents have been found in these cells. Evoked, quantal-like events 
have been detected only after chromaffin cells transfection with the P2X1 subunit-encoding 
gene, but they display unusual kinetics (Hollins and Ikeda, 1997). PC12 cells seem then to be 
more useful, because of their endogenous P2X2 expression and, not last, practical convenience 
in cell preparation with respect to the classical bovine (or rodent) chromaffin cells. 
 
In order to consider PC12 cells as a good model to study events analogous to those occurring at 
synapses, attention should be paid to the choice of the trigger for STICs induction. The use of 
KCl to induce STICs should avoid interference with receptor occupancy , desensitization and 
deactivation. These complications might be expected to arise with the use of ATP, even if 
preliminary data (4 cells) have indicated that STICs evoked by ATP or KCl have similar 
characteristics in terms of amplitude, decay and time-course. It seems feasible that a careful 
choice of the stimulus intensity (and, thus, of the amount of Ca2+ entering into the cells) might 
help to calibrate STIC occurrence at the desired frequency, thus mimicking high- or low- 
probability release sites. This protocol might be useful, for instance, for testing drugs acting at 
the level of ATP release, its diffusion into the intercellular space and its binding to (and 
activation of) receptors on the post-synaptic-like membrane. 
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An additional, possible use of PC12 cells is as detectors of neurotransmitter release. Indeed, the 
methods usually employed to study ATP release-mediated events have a low temporal and 
spatial resolution. “Real time” ATP level measurements by luciferase assays (reported, for 
instance, for macrophageal ATP release; Beigi and Dubyak, 2000) and by ATP-sensitive 
microelectrodes (Dale et al., 2005; Llaudet et al., 2005) are not fast enough (seconds) and are 
still unable to signal ATP release events at the level of the single cell-to-cell contact. 
Furthermore, these methods might combine ATP release from many sites/cells, making them 
unsuitable to reliably monitor ATP release at the single cell level. In future, it will be 
interesting to investigate “sniffer” patches of PC12 cell membrane to detect (via P2X2 receptor 
activation) release of endogenous ATP. 
 
2. Trigeminal ganglion neurons in culture as model to study P2X3 and TRPV1 
receptors 
The characterization of receptors involved in nociceptive stimuli transmission by sensory 
neurons (P2X3 and TRPV1) has been investigated in another in vitro system, namely TG 
neurons in culture. In order to analyze this issue from the functional point of view, the 
characterization of receptors endogenously expressed by these neurons appears a necessary 
step. The ideal system to this aim would be direct recording from sensory neurons in vivo or 
from the intact ganglion, but only few studies of these preparations have been reported 
(Stebbing et al., 1998; Boada and Woodbury, 2006). In particular, for DRG, Stebbing et al. 
(1998) have not detected any response to topical ATP application in intact DRG neurons, in 
contrast with a number of studies reporting large responses of DRG (and TG) neurons in 
culture to ATP or its analogues (for representative examples, see Cook et al., 1997, Spehr et 
al., 2004 for TG; Cook et al., 1998; Burgard et al., 1999, Sokolova et al., 2001 for DRG). This 
discrepancy might be accounted for by the presence of low, P2X3-desensitizing amounts of 
ATP in the intact ganglia as a consequence of experimental manipulation, which could mask 
the response to exogenously applied ATP. In addition, taking into account the fast rise time of 
P2X3 receptor-mediated responses and their rapid, strong desensitization, the relatively slow 
method of agonist application and/or an extensive enzymatic breakdown of extracellular ATP 
could have led to the absence of response. As suggested by North (2002) and confirmed in our 
study, culturing neurons might have led to an increased P2X3 receptor expression and/or 
trafficking to the neuronal membrane, thus facilitating observation of ATP-mediated responses. 
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Even if the technical difficulties of recordings from intact ganglia or from acutely dissociated 
TG (or DRG) neurons could be overcome, these cells are unsuitable models to continuously 
monitor changes in receptor expression or function during long time frames (days). For this 
reason, the development and characterization of TG cultures (described in the work reported in 
this thesis) has been carried out. 
Both mouse and rat TG neurons have shown a good viability in culture, even if the latter 
appear to be more stable after a few days in vitro. The finding that the number of neurons 
expressing “pain receptors” (P2X3 and TRPV1) is increased in culture in comparison to the 
ganglion is important, because it indicates, as expected, that culture model is a useful, but not 
perfect mirror of the in vivo condition, thus suggesting limits as well as advantages of the 
culture as a model system. In this respect, an interesting point is that, in contrast to P2X3 and 
TRPV1, P2X2 receptor expressing neurons are equally abundant in culture and in ganglia: 
previous reports have indicated a global increase in the expression of P2X3 receptors in TG 
neurons after axotomy (Eriksson et al., 1998), thus suggesting that P2X3 receptor expression 
can be modulated by axotomy (occurring during cell culture preparation), while that of P2X2 
receptor might not. Whether this means lack of involvement of P2X2 receptors in the plastic 
changes of nociceptors following neuronal damage remains to be elucidated. 
Nociceptors represent the principal interest of the present research, therefore functional 
experiments (calcium imaging and patch clamping) have been performed on neurons of small 
to medium somatic diameter, which were mainly purinergic nociceptive sensory neurons (see 
Introduction) as validated in the present project. Rat and mouse TG neurons in culture appear 
morphologically similar. In addition, when comparing neurons of the two species at the first 
day after cell plating, they are comparable in terms of cell size, as deduced by the similar 
values of cell capacitance (slow component; A. Fabbro, unpublished) and this might be an 
indication of a conserved phenotype of TG neurons among these two species. 
 
P2X receptors 
In addition to the expression of P2X3 receptors by TG, the functionality of these receptors has 
been analyzed, not only because of the obvious interest in their responses, but also because the 
anti-P2X3 antibody employed in the immunocytochemical study recognizes an intracellular 
epitope of P2X3 receptor, thus labelling also intracellular receptors. This issue has been 
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addressed by using the ATP analogue α,β-meATP, in order to activate homomeric or 
heteromeric P2X3 subunit-containing receptors (North, 2002).  
α,β-meATP is usually referred to as a selective agonist for P2X3 subunit-containing receptors, 
but it can also activate the P2X1 ones (North, 2002). Since the mRNA coding for P2X1 is also 
present in TG neurons (Xiang et al., 1998), it has been necessary to clarify if the latter are 
present and functional in TG cultures: the almost complete suppression of α,β-meATP-induced 
currents by A-317491, at a concentration selective for the P2X3 receptor, but not for P2X1 (1 
µM; Jarvis et al., 2002), excluded a major role of P2X1 receptors in the α,β-meATP-evoked 
responses in TG neurons. A full dose-response curve has been then constructed for this agonist, 
showing an almost perfect overlapping of the responses obtained from rat and mouse neurons. 
  
Immunocytochemical experiments have shown a lower level of colocalization between P2X3 
and P2X2 receptors in mouse with respect to rat neurons, implying that mouse neurons express 
either fewer homomeric P2X2 receptors, or fewer heteromeric P2X2/3 receptors. The analysis of 
the currents elicited by α,β-meATP or ATP application can help to understand this 
phenomenon from the functional point of view. P2X3 receptors are known to desensitize 
almost completely during a 2 s-long  α,β-meATP or ATP application. Heteromeric P2X2/3 
show minimal desensitization like homomeric P2X2 receptors (the latter do not respond to α,β-
meATP; Ralevic and Burnstock, 1998; North, 2002). These properties make the residual 
current detected at the end of a 2 s-long α,β-meATP application (Iresidual) an indication of the 
expression of heteromeric P2X2/3 receptors. Because Iresidual for α,β-meATP is larger in rat than 
in mouse neurons, it seems likely that the first express a larger amount of P2X2/3 heteromers 
than the latter. These findings are in good agreement with immunocytochemistry data obtained 
both in culture and in the ganglia. The physiological meaning of the species-specific 
differential expression of P2X2/3 receptors and, in general, their role in the transmission of 
sensory inputs by TG neurons remain unclear. The expression of P2X2/3 receptors has been 
reported for both TG and DRG neurons and their slow or absent desensitization has led to the 
suggestion of a possible role in pain transmission under chronic or repetitive stimulation 
(North, 2002). Nevertheless, no direct evidence has been provided in this respect and, in 
contrast, their expression and function have been found to be unaffected in a neuropathic pain 
model (Kim and Chung, 1992). Nonetheless, even if the present study has shown that the 
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fraction of TG neurons expressing heteromeric P2X2/3 receptors is not negligible, these 
receptors seem to play a limited role in the responses to α,β-meATP. 
A fundamental point in the characterization of TG cultures as a model system is that, if the 
modulatory effects by long-term exposure to certain mediators are to be investigated, the 
functional expression of receptors should be stable in culture. In our project, this seems indeed 
to be the case, because both the fraction of neurons responding to α,β-meATP and the currents 
obtained in response to it were well conserved for three days after plating, thus making the 
cultures suitable for investigating long term plastic changes in receptor activity. 
 
TRPV1 receptors 
TG neurons in culture have also been characterized for their TRPV1 receptor function. To this 
aim, a standard test dose of 1 µM capsaicin has been used. This capsaicin concentration has 
been chosen because it readily evokes sub-maximal inward currents in sensory neurons 
(Koplas et al., 1997). Even if the construction of a full capsaicin dose-response curve is 
difficult because of strong tachyphylaxis (Koplas et al., 1997), a higher (10 µM) capsaicin dose 
evoked a larger current, thus indicating a non-saturated response to 1 µM capsaicin (A. Fabbro, 
unpublished). Functional and immunocytochemical studies showed that functional TRPV1 
receptors were present in both rat and mouse TG neurons, but the first were more prone to 
express functional TRPV1 receptors than the latter. 
Like P2X3 receptors, TRPV1 receptor-mediated currents were quite stable during the first days 
in culture, with a trend for a decrease only at the third day after plating: as no protein loss has 
been detected at this time point, the response decrease might be accounted for by post-
translational modifications or internalization of the receptor. 
 
In summary, the first part of the work performed on TG neurons has shown that both rat and 
mouse cultures can be reliable models to study P2X3 and TRPV1 receptors function. Neurons 
show good viability and express receptors stable in terms of expression and function. While rat 
TG neurons seem a convenient model to study TRPV1 receptors, in view of their wider 
receptor expression with respect to the mouse ones, both rat and mouse TG neurons are 
suitable systems to study the activity of P2X3 receptors. Additionally, mouse TG neurons in 
culture rarely show functional heteromeric P2X2/3 receptors, and might therefore serve as a 
reliable model for the study of native homomeric P2X3 receptors. 
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3. Effects of chronic NGF or 5-HT exposure of cultured TG neurons on P2X3 and 
TRPV1 receptor function 
The characterization of the experimental system in its basal conditions has represented the 
background for the subsequent functional studies in which slow, delayed changes in “pain 
receptor” function induced by mediators involved in certain pathological states (e.g. 
inflammation and migraine; NGF, 5-HT) has been confirmed, thus showing that the plastic 
changes in P2X3 and TRPV1 receptor expression found in the early culture period with respect 
to the ganglion did not prevent upregulation by putative algogens. 
 
Nerve Growth Factor 
Although the basal amount of endogenous NGF in TG cultures is relatively low, NGF levels 
strongly increase in certain chronic pain states (e.g. headache, inflammatory pain; see 
Introduction), and peak 24 hours after the induction of experimental inflammation (Donnerer et 
al., 1992). In addition, the effective NGF concentration at the level of peripheral terminals of 
sensory neurons is probably much higher than the one measured in the bulk tissue or in the 
serum. Therefore, the effect of a long term exposure of cultured TG neurons to an excessive 
amount of NGF has thus been investigated in the present thesis. The finding that the 
responsiveness to a test pulse of α,β-meATP was increased by such a treatment indicates that 
the function of P2X3 receptors was significantly enhanced. 
NGF levels in the cerebrospinal fluid are increased in some forms of headache, and NGF is 
known to induce the neosynthesis and release of CGRP by sensory neurons (Lindsay and 
Harmar, 1989; Supowit et al., 2001). Taking into account that CGRP strongly potentiates P2X3 
receptor-mediated responses, at least in the time frame of 1 hour (present thesis), the possibility 
that NGF exerts its action on P2X3 receptors via CGRP should not be neglected: however, this 
seems not to be the case, because inhibition of CGRP receptor activity does not prevent the 
potentiation of P2X3 receptor-mediated responses by chronic NGF treatment (A. Fabbro, 
unpublished). The action of NGF in vitro seems, thus, to be independent from CGRP.  
 
The potentiation of P2X3 receptor function by NGF reported in this thesis accords with an in 
vivo study reporting enhanced P2X3 receptor expression in sensory neurons after chronic 
intrathecal NGF administration (Ramer et al., 2001) and indicates that, during inflammation, 
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the enhanced responsiveness of P2X3 receptors by sensory neurons might account, in part, for 
the hyperalgesia typical of this pathological condition. 
The small, but significant increase in the number of sensory neurons expressing functional 
P2X3 receptors (i.e., responding to the application of α,β-meATP) might be an additional, 
indirect indication of a role of P2X3 receptors in inflammatory states. The existence of a subset 
of nociceptors innervating skin, joints and viscera which do not respond to noxious stimuli in 
normal conditions, but can become responsive to a variety of chemical mediators as a 
consequence of inflammation or tissue injury have indeed been described (Millan, 1999): 
accordingly, the reported increase in the number of P2X3 receptor-expressing neurons might 
take place during inflammation (that is, when NGF levels are significantly elevated; Pezet and 
McMahon, 2006), thus possibly contributing to inflammation-induced primary hyperalgesia. 
 
The specificity of action of NGF has been then investigated, by analyzing its action on the 
activity of TRPV1 receptors. The lack of effect of a chronic (24 hours) NGF treatment on the 
amplitude of current mediated by these receptors is in contrast with the strong, potentiating 
action of NGF when it is acutely applied to TG neurons (and, analogously, to DRG ones; Shu 
and Mendell, 2001; Bonnington and McNaughton, 2003) and with its boosting effect on the 
activity of P2X3 receptors. This behavior is unlikely to reflect a different sensitivity of TRPV1 
receptors to NGF action with respect to P2X3 receptors, because NGF acutely applied to TG 
neurons in control conditions can readily potentiate capsaicin-induced currents. A possible 
explanation might be the presence of negative-feedback mechanisms, for instance receptor 
dephosphorylation or internalization (Zhang et al., 2005), bringing the system back to its basal 
level of activity after an initial, transient potentiation by NGF. This hypothesis would, 
nevertheless, require further investigations outside the aims of the present work. 
 
5-HT  
TG neurons express several classes of receptor for 5-HT, including the ionotropic 5-HT3 and a 
number of metabotropic receptors (1B, 1D, 1F, 2, 7; Lazarov, 2002; Hu et al., 2004), which 
can be activated by 5-HT released mainly by platelets, mast cells and perivascular 
serotoninergic nerves (Millan, 1999). 5-HT is a substance typically viewed as a major player in 
migraine pathogenesis (Goadsby, 2000; Goadsby et al, 2002; Silberstein, 2004). Indeed, during 
migraine pain, serum 5-HT levels reach concentrations in the order of µM which last for 
 38 
several hours after the beginning of the attack (Ferrari et al., 1989; Ribeiro et al, 1990). Thus, 
the possibility that the chronic exposure of TG neurons to a relatively large amount of 5-HT 
might modulate the activity of the main “pain receptors” on TG neurons has been preliminary 
tested. In contrast to NGF, 5-HT treatment shows no effect on the current mediated by P2X3 
receptors, but it strongly potentiates the TRPV1-mediated one, thus demonstrating (in analogy 
with the action of NGF on P2X3 receptors) that TRPV1 receptors of TG neurons in culture 
could be pharmacologically potentiated . This finding is in accordance with the acute 
potentiating effect mediated by metabotropic 5-HT receptors on the activity of TRPV1 
receptors expressed by visceral DRG afferents (Sugiura et al., 2004). Nakazawa and Ohno 
(1997) have demonstrated that acute 5-HT application has no effect on the current mediated by 
P2X3 receptors in transfected oocytes, thus making a modulatory action of 5-HT on P2X3 
receptors unlikely in both the short and the long term. 
 
The present findings are clearly only a preliminary description of the effect of a chronic NGF 
or 5-HT application on P2X3 and TRPV1 receptors. Further investigations will be necessary to 
disclose the molecular mechanisms accounting for this phenomenon. However, the differential, 
selective effects of chronic NGF and 5-HT treatments on P2X3 and TRPV1 receptors, 
respectively, suggest the intriguing hypothesis of a discrete regulation of these pain receptors 
by certain substances, whose balance might direct the nociceptive response toward a purinergic 
or a vanilloid phenotype. 
 
4. Modulation of P2X3 receptor activity by desensitization: new molecular 
determinants 
The activity of P2X3 receptors expressed by sensory neurons is largely influenced by their 
strong desensitisation and the slow, Ca2+ dependent recovery from it, a phenomenon which can 
account for a form of short-term receptor memory (Cook et al 1998; Giniatullin et al 2003; see 
Introduction). Therefore, the desensitization process raises particular interest as a potential site 
responsible for receptor dysfunction in pain states, and its molecular determinants have been 
analyzed in P2X3 receptors expressed in HEK cells. Indeed, recent advances concerning the 
identity and function of ATP receptors and their participation in pain processes have been 
obtained by molecular cloning of both ionotropic and metabotropic ATP receptors (North, 
2002; North, 2004; Ruan and Burnstock, 2003). 
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One of the most interesting points of the reported work is the demonstration of a spatial 
segregation of the molecular sites involved in the onset of receptor desensitization, recovery 
from it, sensitivity to the potentiating action of Ca2+, and agonist potency. The segregation 
between desensitization onset and recovery, and the involvement of the extracellular domain of 
P2X3 receptors in the desensitization process have also been described by Zemkova et al. 
(2004), who have shown that P2X2 receptors display unaltered desensitization onset, but 
slower recovery, when expressed as chimeras including a portion of the extracellular domain of 
P2X3 receptors, thus confirming the role of specific residues located in this domain in shaping 
receptor desensitization. 
One of the most interesting mutants is D266A. The behavior of P2X3 receptors mutated at this 
position is very similar to that of P2X2 receptors, as far as the slow desensitization onset and 
the fast recovery from it are concerned. However, while P2X2 receptors are readily inactivated 
by increased external Ca2+ levels (Ding and Sachs, 2000), Ca2+ has no effect on D266A-
mutated P2X3 receptors, further indicating that receptor desensitization and Ca2+ sensitivity can 
be structurally distinct phenomena. Another interesting feature of D266A mutant (and of 
D220A one) is its lower agonist potency and efficacy when compared to the wild type P2X3 
receptor. These two mutations might have negatively affected channel gating or agonist 
binding. In this respect, binding studies or single channel recordings could provide further 
insights into the mechanisms underlying the behavior characteristic of these mutated receptors. 
An additional point suitable for further investigation is the complex structural and functional 
relationship between multiple, specific residues in modulating channel function. For instance, 
because some mutations (E161, E187, E270) only partially block the Ca2+ modulatory effect, it 
would be interesting to investigate the activity of double (or multiple) mutated receptors, in 
order to better clarify their contribution to the receptor functional features. Analogously, an 
attractive issue would be to test the results of two mutations with individually opposite effects: 
for instance, the E111A (or the D266A) and the E289A (or the D220A) mutations have 
contrasting consequences for receptor recovery from desensitization. 
 
As already mentioned in the Introduction, P2X3 receptor desensitization and its slow recovery 
could be a protective mechanism for uncontrolled neuronal excitation during sustained receptor 
stimulation by its endogenous agonist. Furthermore, it also offers a potential target for 
pharmacological treatments aimed at inhibiting the transmission of nociceptive inputs. As far 
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as nociceptive TG neurons are concerned, changes in desensitization properties of P2X3 
receptors might contribute to migraine pain, particularly when there are fluctuations in the 
extracellular levels of ATP, Ca2+ and Mg2+. Likewise, relatively large Ca2+ amounts can spread 
from the outer to the inner epidermis in case of skin wounds (together with ATP released from 
damaged cells), thus increasing both the activity and the persistence of the response of P2X3 
receptors expressed on sensory neurons, enhancing the transmission of painful stimuli (see 
Introduction). 
 
5. P2X3 receptors as novel targets for CGRP action: implications for migraine 
The principal aim of the development and characterization of TG cultures has been the 
mimicking of the conditions which trigeminal ganglion neurons are likely to encounter during 
pathological states, like inflammation or a migraine attack. To explore this issue, the effect of 
the putative migraine mediator CGRP on pain receptors of TG neurons has been systematically 
analyzed with this experimental model. Despite the demonstration of an increase in plasma 
CGRP levels and of the efficacy of CGRP receptor antagonists for migraine treatment (see 
Introduction), only few data exist on the precise cellular mechanisms involved in the action of 
this neuropeptide. In particular, acutely applied CGRP has been reported to potentiate TTX-
insensitive Na+ currents in DRG neurons (Natura et al., 2005); in contrast,  even though CGRP 
can exert pronounced vasodilatory effects, CGRP-mediated vasodilation seems to be 
insufficient to excite nociceptors, at least in a 30 minute time frame (Levy et al., 2005), thus 
suggesting other potential targets for CGRP activity. 
In full agreement with the putative pro-algesic action of CGRP, CGRP binding sites are mainly 
expressed in small-to-medium sized TG neurons, expected to be nociceptors, with a strong 
colocalization with the pain transducer receptor P2X3. A trend for a potentiation of P2X3 
receptor-mediated responses by CGRP is present already at relatively low peptide 
concentrations, and reaches a plateau at about 0.5-1 µM. While these concentrations are higher 
than those reported in plasma, these measurements have been carried with jugular or cubital 
venous blood, in which the CGRP concentration is probably strongly diluted with respect to its 
putative, meningeal site of release (Goadsby et al., 1990; Sarchielli et al., 2000). Indeed, large 
CGRP levels  in vivo near the TG neuronal terminals are likely because high amounts of CGRP 
ready for release are expressed by TG neurons, in particular by meningeal afferents (O’Connor 
and van der Kooy, 1988). It is suggested that the build-up of large local concentrations of the 
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neuropeptide occur, via autocrine stimulation, in conditions of high neuronal activity and/or 
neurogenic inflammation (Millan, 1999; Durham and Russo, 2002). In this respect, it would be 
interesting to explore the effects of CGRP on P2X3 receptors of TG meningeal afferents, in 
order to assess the specificity of action of CGRP on them with respect to TG afferents 
innervating other cranial sites. 
 
Mechanisms of CGRP action on pain-transducing receptors 
The potentiating action of CGRP on P2X3-mediated responses has been shown to depend on 
the activity of both protein kinase A (PKA) and protein kinase C (PKC), but their precise sites 
of action are not known. The PKA and PKC dependence might be indirect, via phosphorylation 
of unknown intracellular molecules by the two kinases, or direct by phosphorylation of the 
P2X N-terminal site by PKC (Vial et al., 2004). While no PKA consensus sites have, however, 
been described on the P2X3 molecule, both kinases are involved in the trafficking of other 
receptors such as NMDA ones to the neuronal membrane (Lan et al., 2001; Scott et al., 2003). 
Furthermore, the potentiation of TTX-resistant Na+ currents by CGRP reported for a subset of 
DRG neurons is also PKA- and PKC-dependent (Natura et al., 2005), thus providing further 
suggestions in favour of the recruitment of both kinases by CGRP receptor activation for 
trafficking of P2X3 receptors. 
TRPV1-mediated responses have not been enhanced by CGRP. Indeed, its action seems to be 
selective for P2X3 receptors, probably because of the rare colocalization between TRPV1 and 
CGRP receptors. However, even if the functional colocalization of P2X3 and TRPV1 receptors 
is limited (∼20%), the P2X3 receptor upregulation by CGRP is not restricted to TRPV1 
expressing neurons, because CGRP can potentiate P2X3-mediated responses to the same extent 
in both capsaicin responsive and non responsive TG populations (A. Fabbro, unpublished). 
 
The high level of colocalization between P2X3 receptors and CGRP binding sites (i.e., CGRP 
receptors) is circumstantial evidence for an action of CGRP specifically on CGRP receptor-
expressing TG neurons, and the possibility that the action of CGRP could be indirect, via the 
release of a second messenger from neurons as well as from non-neuronal cells in culture, has 
no evidence to support it. Indeed, treatment of TG neurons with a CGRP-conditioned medium 
has not revealed any potentiation of P2X3 receptor-mediated responses, thus providing no 
indication of the involvement of intermediate substances (A. Fabbro, unpublished). 
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CGRP in migraine pathogenesis 
The CGRP concentration in plasma correlates with the timing and severity of headache during 
a migraine attack (Juhasz et al., 2003, Juhasz et al., 2005). A number of additional clinical data 
point to a fundamental role of CGRP in the pathogenesis of migraine. First, triptans (agonists 
of the serotonergic 5-HT1B/D receptors) are widely used to prevent or relieve migraine attacks. 
They exert a double action in the transmission of pain at the cranial level, namely by inhibiting 
synaptic transmission between primary afferents and second order neurons (Goadsby et al., 
2002) and by antagonizing the elevation of CGRP levels in migraine sufferers (in parallel with 
a relief of pain), via block of synthesis and release of CGRP (Durham and Russo, 2002). 
Recent pharmacological trials show that a CGRP receptor antagonist (BIBN4096BS) is a 
potent and well tolerated antimigraine drug (Olesen et al., 2004; Edvinsson, 2005). 
The upregulation of P2X3 receptors of TG neurons reported in this thesis might then represent 
one of the possible sites of action of CGRP favouring pain transmission specifically at the level 
of the trigeminal ganglion (because this neuropeptide has  no effect on DRG neurons, which 
poorly express its receptor). Although activation of the trigeminovascular system seems to be 
secondary to an intrinsic, abnormal brain activity in migraine pathogenesis (like cortical 
spreading depression; Bolay et al., 2002; Pietrobon and Striessnig, 2003), it represents the 
effective “pain-sensing” element: the release of vasoactive neuropeptides by meningeal 
nociceptors, including CGRP, might contribute to a long lasting sensitization of P2X3 receptors 
expressed on TG neurons, an effect which is likely to persist well after the time during which 
local CGRP levels are increased. The response of P2X3 receptors to ATP would then be 
enhanced: in this respect, it is worth noting that ATP could also stimulate CGRP release via 
P2Y receptors (Zimmermann et al., 2002), thus further contributing to propagate a noxious 
response. The findings reported in the present thesis are therefore in favour of a potentially 
important role of ATP as a pain transmitter for trigeminal sensory neurons during migrainous 
attacks, as originally proposed by Burnstock (1996). 
A highly speculative, but intriguing possibility is that the functional consequences of an 
upregulation of P2X3 receptors could take place at the peripheral terminals of (meningeal) 
nociceptors, but might also favour synaptic transmission between primary TG afferents and 
second order neurons in the brainstem. In fact, central terminals of sensory neurons express 
P2X3 receptors (which can be activated by ATP locally released by primary afferents 
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themselves or by spinal cord -and, perhaps, also brainstem- neurons; Jo and Schlichter, 1999; 
Burnstock, 2001) and might also release CGRP (Storer et al., 2004; Fischer et al., 2005). Thus, 
it is not unlikely that, following long-lasting, sustained activity of CGRP-containing 
nociceptors, CGRP could reach a sufficiently high and peristent local concentration at the level 
of central terminals of primary afferents. This process might enhance neuronal depolarization 
and calcium entry in the presence of ATP, leading to the central sensitization observed in 
chronic pain states. 
 
6. Specificity of NGF action: responses to GABA and ATP of DRG neurons 
Our work has demonstrated that a long-term NGF exposure of TG neurons in culture boosts 
P2X3 receptors activity, while leaving that of TRPV1 ones unaffected. The last part of the work 
described in the present thesis therefore deals with the specificity of action of NGF, by 
analyzing its effect on inhibitory receptors expressed on sensory neurons, namely the GABAA 
ones. 
The lack of effect of NGF treatment on the amplitude of GABA-induced currents of DRG 
neurons in the first days in culture accords with previous findings (Aguayo and White, 1992; 
Bevan and Winter, 1995; Oyelese et al., 1997). However, previous reports have not taken into 
account changes in current kinetics, and in particular its fading during GABA application 
(desensitization), which could be potentially important for the phenomenon of primary afferent 
depolarization, providing an indication of the persistence of GABA action (see Introduction). 
NGF has been found to improve desensitization (and deactivation) of GABA-, but not ATP-, 
induced currents. The latter finding is in agreement with the unaltered desensitization of P2X3 
receptor-mediated currents with chronically-applied NGF to TG neurons (A. Fabbro and R. 
Giniatullin, unpublished). Remarkably, no significant increase in ATP current amplitude by 
NGF in DRG neurons has been found, in accordance with data by Bevan and Winter (1995) 
after a 1-2 week long NGF treatment of DRG neurons. Nevertheless, this finding contrasts with 
the potentiating action (1 day NGF exposure) of P2X3 receptors of TG neurons (present thesis). 
It would therefore be interesting to explore if the distribution of the high-affinity receptor for 
NGF (TrkA) among P2X3 receptor-expressing neurons is different between DRG and TG 
neurons. DRG and TG neurons differ in several biochemical markers as, for instance, P2X3 
receptors are expressed in small, medium and large size neurons in TG, while they are 
restricted to small size neurons in DRG; the colocalization between P2X3 receptors and the 
 44 
neuropeptide CGRP is significantly higher in TG with respect to DRG neurons (Ambalavanar 
et al., 2005); furthermore, they also differ in the extent of CGRP receptor expression and, 
therefore, in the sensitivity to its modulatory action (present thesis). 
 
7. Conclusions 
The work reported in the present thesis has clarified some aspects of the functional features of 
the main “pain transducing” receptors expressed by primary sensory neurons, in the context of 
a characterization of the in vitro model system suitable to study them. In particular, cultures of 
PC12 cells have been shown to be a good model to study quantal-like events (mediated by 
P2X2 receptors) induced by release of endogenous ATP, suggesting a useful method to study 
ATP release-mediated events. The search for a suitable in vitro model to study P2X receptor 
activity has then moved to trigeminal ganglion neurons in culture. The focus on P2X3 “pain 
receptors” has led to the finding of their selective potentiation by long-lasting exposures to 
NGF or CGRP, while the function of TRPV1 receptors has been shown to be specifically 
enhanced by a long-term 5-HT treatment, putting forward the possibility of a selective, 
differential regulation of distinct purinergic and vanilloid pain-signalling pathways. 
These findings, together with the identification of molecular targets for the modulation of P2X3 
receptor function, add further evidence in favour of the fundamental role of P2X3 (and TRPV1) 
receptors in pain transmission. These receptors, and the substances which positively modulate 
them, might be suitable targets for new pharmacological treatments aiming at inhibiting 
nociceptive inputs from primary nociceptors to higher levels of the central nervous system. 
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